Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer
- 19 April 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 40, 116129
Abstract
No abstract availableKeywords
Funding Information
- Ralph W and Grace M Showalter Research Trust Fund
- NIGMS
This publication has 87 references indexed in Scilit:
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?Clinical Cancer Research, 2012
- A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and LymphomasClinical Cancer Research, 2011
- The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60Cell Death & Disease, 2011
- Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancerThe FEBS Journal, 2011
- Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor CellsCancer Research, 2010
- Cytosolic Hsp60 Is Involved in the NF-κB-Dependent Survival of Cancer Cells via IKK RegulationPLOS ONE, 2010
- Systematic Comparative Protein Expression Profiling of Clear Cell Renal Cell CarcinomaMolecular & Cellular Proteomics, 2009
- Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survivalBMC Gastroenterology, 2009
- Guidelines for the nomenclature of the human heat shock proteinsCell Stress and Chaperones, 2008
- Evidence for the Rapid Conversion of Stephacidin B into the Electrophilic Monomer Avrainvillamide in Cell CultureJournal of the American Chemical Society, 2007